Amelie Bernier-Jean1, Germaine Wong2, Valeria Saglimbene2,3, Marinella Ruospo3, Suetonia C Palmer4, Patrizia Natale2,3, Vanessa Garcia-Larsen5, David W Johnson6,7, Marcello Tonelli8, Jörgen Hegbrant9, Jonathan C Craig10, Armando Teixeira-Pinto2, Giovanni F M Strippoli2,3. 1. School of Public Health, Faculty of Medicine and Health, The University of Sydney, Sydney, Australia aber0398@uni.sydney.edu.au. 2. School of Public Health, Faculty of Medicine and Health, The University of Sydney, Sydney, Australia. 3. Department of Emergency and Organ Transplantation, University of Bari, Bari, Italy. 4. Department of Medicine, University of Otago, Christchurch, New Zealand. 5. Program in Human Nutrition, Department of International Health, The Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland. 6. Department of Nephrology, Princess Alexandra Hospital, Brisbane, Australia. 7. Australasian Kidney Trials Network, University of Queensland, Brisbane, Australia. 8. University of Calgary, Calgary, Canada. 9. Department of Nephrology, Lund University, Lund, Sweden. 10. College of Medicine and Public Health, Flinders University, Adelaide, Australia.
Abstract
BACKGROUND AND OBJECTIVES: Dietary potassium restriction in people receiving maintenance hemodialysis is standard practice and is recommended in guidelines, despite a lack of evidence. We aimed to assess the association between dietary potassium intake and mortality and whether hyperkalemia mediates this association. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: A total of 8043 adults undergoing maintenance hemodialysis in Europe and South America were included in the DIETary intake, death and hospitalization in adults with end-stage kidney disease treated with HemoDialysis (DIET-HD) study. We measured baseline potassium intake from the Global Allergy and Asthma European Network food frequency questionnaire and performed time-to-event and mediation analyses. RESULTS: The median potassium intake at baseline was 3.5 (interquartile range, 2.5-5.0) g/d. During a median follow-up of 4.0 years (25,890 person-years), we observed 2921 (36%) deaths. After adjusting for baseline characteristics, including cardiac disease and food groups, dietary potassium intake was not associated with all-cause mortality (per 1 g/d higher dietary potassium intake: hazard ratio, 1.00; 95% confidence interval [95% CI], 0.95 to 1.05). A mediation analysis showed no association of potassium intake with mortality, either through or independent of serum potassium (hazard ratio, 1.00; 95% CI, 1.00 to 1.00 and hazard ratio, 1.01; 95% CI, 0.96 to 1.06, respectively). Potassium intake was not significantly associated with serum levels (0.03; 95% CI, -0.01 to 0.07 mEq/L per 1 g/d higher dietary potassium intake) or the prevalence of hyperkalemia (≥6.0 mEq/L) at baseline (odds ratio, 1.11; 95% CI, 0.89 to 1.37 per 1 g/d higher dietary potassium intake). Hyperkalemia was associated with cardiovascular death (hazard ratio, 1.23; 95% CI, 1.03 to 1.48). CONCLUSIONS: Higher dietary intake of potassium is not associated with hyperkalemia or death in patients treated with hemodialysis.
BACKGROUND AND OBJECTIVES: Dietary potassium restriction in people receiving maintenance hemodialysis is standard practice and is recommended in guidelines, despite a lack of evidence. We aimed to assess the association between dietary potassium intake and mortality and whether hyperkalemia mediates this association. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: A total of 8043 adults undergoing maintenance hemodialysis in Europe and South America were included in the DIETary intake, death and hospitalization in adults with end-stage kidney disease treated with HemoDialysis (DIET-HD) study. We measured baseline potassium intake from the Global Allergy and Asthma European Network food frequency questionnaire and performed time-to-event and mediation analyses. RESULTS: The median potassium intake at baseline was 3.5 (interquartile range, 2.5-5.0) g/d. During a median follow-up of 4.0 years (25,890 person-years), we observed 2921 (36%) deaths. After adjusting for baseline characteristics, including cardiac disease and food groups, dietary potassium intake was not associated with all-cause mortality (per 1 g/d higher dietary potassium intake: hazard ratio, 1.00; 95% confidence interval [95% CI], 0.95 to 1.05). A mediation analysis showed no association of potassium intake with mortality, either through or independent of serum potassium (hazard ratio, 1.00; 95% CI, 1.00 to 1.00 and hazard ratio, 1.01; 95% CI, 0.96 to 1.06, respectively). Potassium intake was not significantly associated with serum levels (0.03; 95% CI, -0.01 to 0.07 mEq/L per 1 g/d higher dietary potassium intake) or the prevalence of hyperkalemia (≥6.0 mEq/L) at baseline (odds ratio, 1.11; 95% CI, 0.89 to 1.37 per 1 g/d higher dietary potassium intake). Hyperkalemia was associated with cardiovascular death (hazard ratio, 1.23; 95% CI, 1.03 to 1.48). CONCLUSIONS: Higher dietary intake of potassium is not associated with hyperkalemia or death in patients treated with hemodialysis.
Authors: Arti Sharma Parpia; Marc B Goldstein; JoAnne Arcand; France Cho; Mary R L'Abbé; Pauline B Darling Journal: J Acad Nutr Diet Date: 2018-01-06 Impact factor: 4.910
Authors: Suetonia C Palmer; Camilla S Hanson; Jonathan C Craig; Giovanni F M Strippoli; Marinella Ruospo; Katrina Campbell; David W Johnson; Allison Tong Journal: Am J Kidney Dis Date: 2014-11-06 Impact factor: 8.860
Authors: Christiane I Ramos; Ailema González-Ortiz; Angeles Espinosa-Cuevas; Carla M Avesani; Juan Jesus Carrero; Lilian Cuppari Journal: Nephrol Dial Transplant Date: 2021-11-09 Impact factor: 5.992
Authors: Valeria M Saglimbene; Germaine Wong; Marinella Ruospo; Suetonia C Palmer; Vanessa Garcia-Larsen; Patrizia Natale; Armando Teixeira-Pinto; Katrina L Campbell; Juan-Jesus Carrero; Peter Stenvinkel; Letizia Gargano; Angelo M Murgo; David W Johnson; Marcello Tonelli; Rubén Gelfman; Eduardo Celia; Tevfik Ecder; Amparo G Bernat; Domingo Del Castillo; Delia Timofte; Marietta Török; Anna Bednarek-Skublewska; Jan Duława; Paul Stroumza; Susanne Hoischen; Martin Hansis; Elisabeth Fabricius; Paolo Felaco; Charlotta Wollheim; Jörgen Hegbrant; Jonathan C Craig; Giovanni F M Strippoli Journal: Clin J Am Soc Nephrol Date: 2019-01-31 Impact factor: 8.237
Authors: Amanda J Vinson; Wayel Zanjir; Megi Nallbani; Judah Goldstein; Janel Swain; David A Clark; Keigan M More; John R Manderville; Patrick T Fok; Hana Wiemer; Karthik K Tennankore Journal: Kidney360 Date: 2022-02-09
Authors: Gregorio Romero-González; Jordi Bover; Javier Arrieta; Davide Salera; Maribel Troya; Fredzzia Graterol; Pablo Ureña-Torres; Mario Cozzolino; Luca Di Lullo; Pietro E Cippà; Marina Urrutia; Javier Paúl-Martinez; Ramón Boixeda; José Luis Górriz; Jordi Ara; Antoni Bayés-Genís; Antonio Bellasi; Claudio Ronco Journal: J Clin Med Date: 2022-07-08 Impact factor: 4.964